These lethal changes in India’s patent rules
The proposed amendments are a capitulation to Big Pharma and will undermine vital public health safeguards in the law
Gilead granted patent for hepatitis C drug Solvadi
The move is being seen as a possible impact of Indian Prime Minister Narendra Modi’s proposed visit to the US next month
More Indian residents filing patents than MNCs despite challenges: Economic Survey
India still lags behind China, the United States, Japan and South Korea despite an increase in the number of patents being filed
Lethal hypocrisy of US Special 301 Report
Patent protection in the US is a convoluted and expensive business and yet it pulls up other countries that have robust systems
Why Modi's razzmatazz diplomacy isn't serving African interests
Missing from Modi’s foreign trips is a focus on issues most pressing for Africa’s people
Getting the drug equation right
Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety